Grant

Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)

CountryUnited States
DeadlineNot published
Published2026-03-04
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity PAR-26-132. CFDA: 93.866

The buyer, the value, the full description and the link to the official notice are available with a free account.